Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Freenome partners with Biognosys to develop cancer screen

April 27, 2018 7:52 PM UTC

Freenome Inc. (South San Francisco, Calif.) partnered non-exclusively with Biognosys AG (Schlieren, Switzerland) to enhance Freenome’s AI-based genomics platform for detecting cell-free biomarkers. Biognosys will use its parallel mass spectrometry platform to build plasma proteome datasets for use with Freenome's AI platform to develop a cancer screen...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Biognosys AG

Freenome Inc.